Discovery PR

Activities: Marketing

Trending Articles

  1. Advanced mass spectrometry technique breaks free from specialist hardware Researchers at the University of Warwick and spin-out company Verdel Instruments have successfully demonstrated two-dimensional mass spectrometry (2DMS) on a benchtop...
  2. Merck-backed Ebola vaccine moves towards clinical manufacturing Hilleman Laboratories will manufacture an investigational Bundibugyo Ebola vaccine for clinical trials, as the DRC outbreak drives renewed focus on rapid vaccine development...
  3. Eli Lilly’s retatrutide hits Phase III goals with FDA filing planned for 2027 Lilly’s triple GIP/GLP-1/glucagon agonist delivered up to 22.6% weight loss in two Phase III trials, with the company now completing its CMC package ahead of a planned US...
  4. Touchlight’s dbDNA used in first UK personalised lung cancer vaccine The first UK patient has received a personalised DNA cancer vaccine manufactured using Touchlight’s cell-free dbDNA technology, in a Phase I trial investigating a potential...
  5. Gerresheimer is selling Centor and its global Primary Packaging Plastics business to Apax Funds Significant optimisation of the capital and financing structure through expected cash inflows, meaningfully decreasing leverage

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all